U.S. Personal Products Stock News

Royal Gold restructured its interest in the Hod Maden Project, exchanging its direct ownership stake for a 2.5% net smelter return royalty. The transaction involved selling part of its equity stake to project partner Lidya Mines while retaining exposure through future royalty payments. This move reduces Royal Gold's exposure to project capital and operating costs and increases its focus on royalty based income. Royal Gold, ticker NasdaqGS:RGLD, recently experienced mixed share price...

Carl Icahn’s renewed bullish stance on CVR Partners (UAN), along with increased ownership and a quarterly cash distribution nearly 80% higher than a year earlier, is pulling fresh investor attention to the nitrogen fertilizer producer. See our latest analysis for CVR Partners. The share price tells a mixed story, with a 17.44% 90 day share price return and a 24.95% year to date share price return. At the same time, the 1 year total shareholder return of 71.76% and 5 year total shareholder...

Over the last 7 days, the United States market has experienced a slight decline of 1.0%, yet it remains up by an impressive 23% over the past year, with earnings forecasted to grow by 17% annually. In such a fluctuating environment, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervalued assets.

Over the last 7 days, the United States market has experienced a 1.0% drop, yet it remains up by 23% over the past year, with earnings projected to grow by 17% annually in the coming years. In this context of overall market growth and temporary fluctuations, stocks with high insider ownership can offer valuable insights into potential long-term performance as insiders' confidence may align their interests with those of other shareholders.

Over the last 7 days, the U.S. market has dropped by 1.0%, yet it has risen by 23% over the past year, with earnings forecasted to grow annually by 17%. In such a fluctuating market, identifying stocks with strong fundamentals and growth potential is crucial for investors seeking stability and opportunity. While "penny stocks" may sound like an outdated term, they continue to represent smaller or less-established companies that can offer significant value; we've identified three such stocks...

Over the last 7 days, the United States market has experienced a slight dip of 1.0%, yet it has shown impressive growth of 23% over the past year, with earnings anticipated to increase by 17% annually in the coming years. In such dynamic conditions, identifying lesser-known stocks with strong fundamentals and growth potential can offer unique opportunities for investors seeking to diversify their portfolios.

Apparel industry groups linked to African manufacturing, including those involving Levi Strauss (NYSE:LEVI), are raising concerns about the instability created by short-term renewals of U.S. trade agreements with African countries. Unions are also calling for tighter labor-rights enforcement across African apparel supply chains, adding another layer of scrutiny for brands sourcing from the region. For Levi Strauss, which relies on a wide supplier base to support its denim and apparel...

In recent months, Amalgamated Financial reported a solid first quarter with revenue rising year on year and topping analyst expectations, even as earnings per share and tangible book value per share came in below estimates and a single multifamily loan moved to nonaccrual. At the same time, the bank’s net interest margin improved over the past two years while overall revenue growth slowed, highlighting a shift toward more profitable core lending despite a moderating top line and isolated...

Life Time Group Holdings (NYSE:LTH) recently hosted a sold out Chicago Spring Half Marathon & 5K, expanding its community race footprint in a major urban market. The event introduced a Kids Run Final Mile in collaboration with Chicago Public Schools and its Foundation, aimed at encouraging youth fitness and family participation. These initiatives extend Life Time's reach beyond its clubs, focusing on broad community health and accessible entry points for new runners and members. For...

Earlier in May 2026, Zoth announced it had signed a memorandum of understanding with Bakkt, Inc., using Bakkt’s licensed subsidiary Bakkt Financial Solutions I, LLC to underpin a planned cross‑border payments offering that combines Bakkt’s US regulatory infrastructure with Zoth’s emerging‑market payment corridors and local operations. The arrangement positions Bakkt as the regulated backbone for Zoth’s enterprise money transfer clients, potentially enhancing Bakkt’s role in compliant,...

Pediatrix Medical Group (MD) is back in focus after its latest Q1 update, where management reported improved profitability, stronger cash collections, reaffirmed 2026 EBITDA guidance, and highlighted continued growth in core neonatal and maternal-fetal care services. See our latest analysis for Pediatrix Medical Group. At a share price of US$23.01, Pediatrix Medical Group has a 1-year total shareholder return of 51.78% and a 3-year total shareholder return of 70.07%, while the 5-year total...

Yalla Group (NYSE:YALA) opened 2026 with Q1 revenue of about US$79.0 million and basic EPS of US$0.19, setting a clear marker for how the year is starting after a period of steady profitability. Over recent quarters, the company has seen revenue move from roughly US$83.9 million in Q1 2025 to US$79.0 million in Q1 2026, while basic EPS has shifted from US$0.23 to US$0.19. This gives you a clean read on how the top line and EPS trend into the new year. With trailing twelve month EPS at US$0.92...

Earlier in May 2026, Delek US Holdings refinanced and amended its term loan credit facility, cutting the outstanding balance to US$850,000,000, extending the maturity by six years, and lowering interest costs while tightening loan covenants and maintaining asset-backed security. This refinancing, combined with analysts highlighting Delek as a strong growth candidate and ongoing insider share sales, gives investors new information about the company’s capital structure strength and...

Earlier in May 2026, RingCentral reported first-quarter revenue of US$644.2 million, returned to profitability, affirmed its quarterly dividend, completed a large multi-year share repurchase, raised full-year 2026 guidance, and expanded its AI Receptionist offering with new integrations, channels, and pricing options. An interesting angle is how RingCentral’s rapidly adopted AI Receptionist, now used by more than 11,800 businesses, links product innovation with higher customer engagement...

Knowles (NYSE:KN) is facing long term operational headwinds, with sales and earnings growth trailing the broader business services sector. Recent analysis points to a persistent decline in revenue and weaker earnings per share growth compared with industry peers. These pressures raise questions about the company’s competitive position and long term resilience beyond earlier valuation focused coverage. Knowles, trading at $34.07, has seen its share price move sharply over time, with the...

Papa John's International (NasdaqGS:PZZA) is rolling out its Special Garlic Dipping Sauce to major U.S. grocery chains nationwide. The retail launch includes placement in large banners such as Walmart and Kroger for the first time. This is the company’s first effort to sell a signature menu item through consumer packaged goods channels. Papa John's International enters this grocery launch with its stock at $33.35 and multi year returns that have moved lower, including down 50.2% over 3...

Some AAON, Inc. ( NASDAQ:AAON ) shareholders may be a little concerned to see that the President, Matthew Tobolski...

BioMarin Pharmaceutical (NasdaqGS:BMRN) reported that BMN 401 missed one of two co-primary endpoints in the Phase 3 ENERGY 3 trial for ENPP1 deficiency. The therapy did not show improvement in skeletal health or key secondary outcomes, raising questions about its regulatory and commercial outlook. The result affects BioMarin's rare disease pipeline at a time when the company is working to broaden its revenue base beyond existing treatments. For investors watching rare disease drug...

Cathie Wood's ARK Invest and Ken Griffin have recently added to their positions in Joby Aviation (NYSE:JOBY). The increased holdings come ahead of Joby's planned launch of commercial air taxi services. These investments arrive as Joby reports progress on key FAA certification steps and commercial partnerships. The fresh backing contrasts Joby with competitor Archer Aviation and highlights changing market sentiment toward air taxis. Joby Aviation, trading under NYSE:JOBY, is working on...

Wondering if Danaos at around US$129.81 is still offering value, or if most of the opportunity is already priced in? This article walks through the key signals to help you frame that question clearly. The stock has been relatively active, with the share price down about 2.3% over the past week, up 10.2% over 30 days, up 36.3% year to date, and showing a 58.3% return over the last year, alongside very large multi year gains of more than 7x over five years. These swings in the share price have...

ImmunityBio (NasdaqGS:IBRX) received FDA acceptance for review of its supplemental Biologics License Application for ANKTIVA plus BCG in BCG-unresponsive non-muscle invasive bladder cancer with papillary disease. The company also released new comparison data indicating improved efficacy and safety of ANKTIVA plus BCG versus other approved bladder cancer therapies, presented at a major medical meeting. These developments relate to a potential expansion of ANKTIVA's approved use and could...

Vishay Intertechnology, Inc.'s ( NYSE:VSH ) stock was strong after they recently reported robust earnings. However, we...

Shareholders appeared unconcerned with ICL Group Ltd's ( NYSE:ICL ) lackluster earnings report last week. We did some...

Alset Inc.'s (NASDAQ:AEI) value has fallen 16% in the last week, but insiders who sold US$2.7m worth of stock over the...